MapLight Therapeutics (MPLT) Other Working Capital Changes (2024 - 2025)

MapLight Therapeutics (MPLT) reported Other Working Capital Changes of -$204000.0 for Q4 2025, down 15.91% on a YoY basis from -$242594.6 in Q4 2024, and down 15.91% sequentially from -$176000.0 in Q4 2024.

MapLight Therapeutics (MPLT) Other Working Capital Changes (2024 - 2025) Analysis & Trends

MapLight Therapeutics (MPLT) has 2 years of Other Working Capital Changes data on file, last reported at -$204000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 MapLight Therapeutics 314.07 Mn 314.07 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -204,000.00
Dec 31, 2025 -204,000.00
Dec 31, 2025 -204,000.00
Dec 31, 2024 -176,000.00
Dec 31, 2024 -176,000.00
Dec 31, 2024 -176,000.00